<code id='6BE06230C5'></code><style id='6BE06230C5'></style>
    • <acronym id='6BE06230C5'></acronym>
      <center id='6BE06230C5'><center id='6BE06230C5'><tfoot id='6BE06230C5'></tfoot></center><abbr id='6BE06230C5'><dir id='6BE06230C5'><tfoot id='6BE06230C5'></tfoot><noframes id='6BE06230C5'>

    • <optgroup id='6BE06230C5'><strike id='6BE06230C5'><sup id='6BE06230C5'></sup></strike><code id='6BE06230C5'></code></optgroup>
        1. <b id='6BE06230C5'><label id='6BE06230C5'><select id='6BE06230C5'><dt id='6BE06230C5'><span id='6BE06230C5'></span></dt></select></label></b><u id='6BE06230C5'></u>
          <i id='6BE06230C5'><strike id='6BE06230C5'><tt id='6BE06230C5'><pre id='6BE06230C5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:73
          Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit.
          Priscilla Chan and Mark Zuckerberg appear virtually at the 2023 STAT Summit. STAT

          Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease.

          The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. It joins the original San Francisco Biohub founded in 2016 and a Chicago Biohub founded earlier this year.

          advertisement

          “About the five-year mark, we basically sat down and tried to assess what we thought was working well and what we want to double down on,” Zuckerberg told STAT. “And we thought that the Biohub model to bring a few universities together, coupling that with engineering and a long-term goal, was a model that was really doing well.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Argenx readies a blockbuster opportunity with drug for autoimmune disease
          Argenx readies a blockbuster opportunity with drug for autoimmune disease

          MollyFerguson/STATHaveyouheardthenews?I’mlaunchingaweeklyemailnewsletterstartingonMarch28.It’scalled

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Readout Newsletter: Geron, Novo Nordisk, WuXi updates

          KayanaSzymczakforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote